GF Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

GF Fund Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.53K	Buy	2,588 +211	+9%	+$371	﹤0.01%	587
2026 Q2	$4.64K	Buy	2,377 +56	+2%	+$114	﹤0.01%	573
2026 Q1	$5.71K	Buy	2,321 +279	+14%	+$934	﹤0.01%	600
2025 Q4	$8.13K	Buy	+2,042	New	+$9.04K	﹤0.01%	596

Other funds holding NBP

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GF Fund Management's NBP Position: Q3 2026 in Review

GF Fund Management increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 8.9% in Q3 2026, buying an estimated $371 and bringing the position to 2,588 shares worth $3.53K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

GF Fund Management first reported a position in NBP in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.13K in Q4 2025. 3 funds tracked by Wall St. Rank hold NBP as of Q3 2026.

GF Fund Management held 2,588 shares of NovaBridge Biosciences American Depositary Shares worth $3.53K as of Q3 2026.
GF Fund Management bought 211 NovaBridge Biosciences American Depositary Shares shares in Q3 2026, an estimated $371.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #587 holding.
GF Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 4 quarters since.
GF Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $8.13K in Q4 2025.
3 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.